Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
about
Generalized immune activation as a direct result of activated CD4+ T cell killingEmerging concepts in the immunopathogenesis of AIDSThe lymph node in HIV pathogenesisFunctional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune SuppressionGut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infectionRole of HLA Adaptation in HIV EvolutionAlcohol and HIV Effects on the Immune SystemGut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityPurinergic Receptors: Key Mediators of HIV-1 Infection and InflammationMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyEpstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infectionTranscriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalizationCritical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infectionMaintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treaAlcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infectionsImmune activation and paediatric HIV-1 disease outcomeImmune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infectionAge-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected childrenCross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapyA randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adultsEffects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patientsPhylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS.Systematic identification of synergistic drug pairs targeting HIVHierarchical mixture models for longitudinal immunologic data with heterogeneity, non-normality, and missingness.Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replicationThe risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.Systemic effects of inflammation on health during chronic HIV infectionPerforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activationAssociation between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients.Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.Impact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa.Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.HIV-1 Populations in Semen Arise through Multiple Mechanisms.Tryptophan catabolism and immune activation in primary and chronic HIV infection
P2860
Q21146758-CD7C9735-B6F9-4F68-9681-BB9C40D16A7EQ22241984-B4143F94-205C-4E06-87E7-3C4869F6F0B7Q24644783-6824923B-8C02-4EB9-ADD7-1D6BA5781879Q26744626-9B517043-36DB-450E-BB73-54F7EF174F42Q26748743-D90E3F8C-2934-4AD1-B5D9-95CAA87F3A31Q26772713-AF161407-BEDC-42A4-81F2-FC5B9F310425Q26773216-1407DF25-46A8-46E7-B76D-0F638A2D37F6Q26773267-66E2F8FF-C733-4258-BF8E-4FA6C2A2E2C3Q26774666-2660DAED-C15B-48E2-8DE6-F91E03C1693AQ27015778-328431EB-346C-458A-ABAE-FB8E62E2DB80Q27022706-BED53FB3-ED81-467A-9AFC-3739D36CCCAFQ27318045-3BE37325-4C5F-4F0F-ADBC-B661E8F2DB92Q27318086-FC98F7AC-13FC-4A04-A8C7-45F61892AC9CQ27334401-58BF4ABB-C6E9-4C00-A5F6-D29A7615D6B7Q27490328-05DD115A-F7DF-4146-A73D-42D9FE84C155Q28070280-BF877FEE-8E96-4B4A-954A-C8ECFE39F030Q28086888-54FC74C4-65DC-44E6-8707-E016161876EBQ28478654-0836AA50-3BB4-4748-B8C3-5498FA9721BCQ28483967-16DE58AB-C6D5-4077-B40F-03EFEB74B9B4Q28740329-E667140D-4474-4AB3-B96B-EE83115C851BQ28740565-F9A879DD-1303-4153-A8EF-526CE46D94DDQ28748971-82829D75-7659-41B2-BC01-2E94C8026EDEQ30011039-951B4EFA-C97A-4A2E-ADD5-8C3DE63495DEQ30422333-B7CDE55C-28E8-4FA7-A34A-2C225C2A11A4Q30837149-FE9424D0-B43B-4F98-8862-77700621313AQ33326642-5D7C08B9-0528-41B8-96FB-C98C04B8D4B4Q33406497-463D063F-238A-4818-8D8F-4D446BC3D785Q33507274-2B8CAE36-4515-4001-BE64-6AD6A30FE571Q33528999-45D26ACF-5DFC-4C3A-B44B-2843DD478CBEQ33559823-2BCD650C-0420-4A3D-8354-F3FFCFC65A01Q33577551-76BFB2C9-1A7C-4F5D-A7F8-4F6BAACA505BQ33594461-103860E1-5AF2-4C50-B45F-04CBCF2202CCQ33597485-128169F5-E7A2-4E97-A292-D342288C5939Q33602772-B6524062-9274-49AE-9018-0EABE3FB542AQ33608661-CEAA2D26-11B0-4568-B092-0B89FDBFD05BQ33631159-E64B14C4-E6A9-47A0-8E9C-5D16F47F4A86Q33631238-CEE727BB-6234-4817-91FD-39EEF9AC2200Q33649753-E19155FC-F7E4-410D-92F8-6A41E60195F6Q33680752-D30F0203-ED54-4E5B-AD77-D83D4038CF28Q33697163-82B0CB89-9179-4534-8041-AB640249C6D4
P2860
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
description
article
@en
im April 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2004
@uk
name
Immune activation set point du ...... nges independent of viral load
@en
Immune activation set point du ...... nges independent of viral load
@nl
type
label
Immune activation set point du ...... nges independent of viral load
@en
Immune activation set point du ...... nges independent of viral load
@nl
prefLabel
Immune activation set point du ...... nges independent of viral load
@en
Immune activation set point du ...... nges independent of viral load
@nl
P2093
P1433
P1476
Immune activation set point du ...... nges independent of viral load
@en
P2093
Amy B Narváez
Christina M R Kitchen
James O Kahn
Jeffrey N Martin
Michael S McGrath
Peter Hunt
Ron Gascon
Steven G Deeks
P304
P356
10.1182/BLOOD-2003-09-3333
P407
P577
2004-04-29T00:00:00Z